Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.
Open | $6.73 |
Close | $6.76 |
Volume / Avg. | 91.06K / 103.43K |
Day Range | 6.49 - 6.93 |
52 Wk Range | 2.70 - 9.97 |
Market Cap | $374.02M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 3.01% |
Days to Cover | 12.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Adaptimmune Therapeutics (NASDAQ:ADAP).
There is no analysis for Foghorn Therapeutics.
Foghorn Therapeutics has a consensus price target of $14.50.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $6.76 last updated July 26, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.